INGN - Inogen, Inc.
| Previous close | 201.96 |
| Open | 202.49 |
| Bid | 180.10 x 800 |
| Ask | 210.00 x 800 |
| Day's range | 197.67 - 203.55 |
| 52-week range | 89.01 - 209.72 |
| Volume | 131,291 |
| Avg. volume | 228,073 |
| Market cap | 4.212B |
| Beta | 1.02 |
| PE ratio (TTM) | 169.22 |
| EPS (TTM) | 1.17 |
| Earnings date | 3 Aug 2017 - 7 Aug 2017 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 200.60 |
- Zacks•12 days ago
Zacks.com featured highlights include: Johnson Outdoors, Home, Inogen, Blucora and Weight Watchers
Zacks.com featured highlights include: Johnson Outdoors, Home, Inogen, Blucora and Weight Watchers
- Zacks•13 days ago
5 Profitable Stocks to Scoop Up Spectacular Returns
Profitability analysis is one of the best tools to evaluate the future movement of a stock.
- Simply Wall St.•20 days ago
Why Inogen Inc (NASDAQ:INGN) Could Be A Buy
Inogen Inc (NASDAQ:INGN), a medical equipment company based in United States, received a lot of attention from a substantial price increase on the NasdaqGS over the last few months. AsRead More...
- Business Wire•last month
Inogen Announces Participation in 38th Annual William Blair Growth Stock Conference
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 38th Annual William Blair Growth Stock Conference in Chicago.
- Zacks•2 months ago
Inogen (INGN) Beats Q1 Earnings Estimates, Lifts 2018 View
Inogen (INGN) rides on strong domestic and international sales growth in Q1; a raised guidance buoys optimism.
- CNBC•2 months ago
After-hours buzz: CGNX, AKAM & more
See which stocks are posting big moves after the bell.
- Associated Press•2 months ago
Inogen: 1Q Earnings Snapshot
The Goleta, California-based company said it had net income of 48 cents per share. The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research ...
- Business Wire•2 months ago
Inogen Announces Record First Quarter 2018 Financial Results and Increases 2018 Guidance
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month period ended March 31, 2018.
- Business Wire•3 months ago
Inogen to Announce First Quarter 2018 Financial Results on Monday, April 30, 2018
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2018 financial results after market close on Monday, April 30, 2018.
- Reuters•3 months ago
Oxygen device maker Inogen discloses customer data breach
The company, which makes portable devices that supply oxygen to patients with breathing difficulties and lung diseases, said some non-public financial information was also leaked after an employee's email account was compromised. The unauthorized access appeared to have occurred between Jan. 2 and March 14 and involved rental customers' personal information such as names, contact details, Medicare identification numbers and insurance policy information.
- Reuters•3 months ago
Oxygen device maker Inogen discloses customer data breach
The company, which makes portable devices that supply oxygen to patients with breathing difficulties and lung diseases, said some non-public financial information was also leaked after an employee's email account was compromised. The unauthorized access appeared to have occurred between Jan. 2 and March 14 and involved rental customers' personal information such as names, contact details, Medicare identification numbers and insurance policy information.
- Zacks•4 months ago
Why Is Inogen (INGN) Down 7% Since its Last Earnings Report?
Inogen (INGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Business Wire•4 months ago
Inogen Announces Participation in 17th Annual Needham Healthcare Conference
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 17th Annual Needham Healthcare Conference in New York City.
- Zacks•5 months ago
Inogen (INGN) Beats Earnings and Revenue Estimates in Q4
Inogen (INGN) reports impressive Q4 financial results on the back of strong business-to-business and direct-to-consumer sales growth.
- Associated Press•5 months ago
Inogen reports 4Q loss
On a per-share basis, the Goleta, California-based company said it had a loss of 3 cents. Earnings, adjusted for pretax expenses, came to 31 cents per share. The results surpassed Wall Street expectations. ...
- Business Wire•5 months ago
Inogen Announces Fourth Quarter and Full Year 2017 Financial Results and Updates 2018 Guidance
Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month and twelve-month periods ended December 31, 2017.
- Zacks•5 months ago
Is a Beat in Store for Inogen (INGN) This Earnings Season?
Strong product portfolio and a unique direct-to-consumer business model are expected to drive Inogen (INGN) in Q4.
- Zacks•5 months ago
Inogen (INGN) Gains on Diverse Product Line, Competition Rife
Inogen (INGN) rides on POC growth. Existing market challenges likely to mar prospects.
Market Realist•5 months agoA Deep Look at Globus Medical’s Financial Performance
Here's What's in Store for Globus Medical in 2018
Market Realist•5 months agoTaking Stock of Globus Medical’s Recent Acquisitions
Globus Medical (GMED) recently launched a robotic surgical navigation device. Since its inception in 2003, Globus Medical has launched more than 180 products. Globus Medical acquired KB Medical, a Switzerland-based robotic developer, in June 2017.
Market Realist•5 months agoAnalyst Ratings for Globus Medical and Its Peers in February
Globus Medical (GMED) is a medical device company with a focus on designing, developing, and commercializing musculoskeletal solutions. Globus Medical’s sales force is comprised of direct sales representatives and distributor sales representatives employed by exclusive independent distributors. Of the 13 analysts covering Globus Medical in February 2018, seven of them have given the stock a “buy” or higher rating.
Market Realist•5 months agoBehind MiMedx Group’s Recent Financial Performance
Why Investors Are Eyeing MiMedx Group Today
- Market Realist•5 months ago
Why the Physician Office Pain Management Market Matters to MiMedx
Why Investors Are Eyeing MiMedx Group Today
Market Realist•5 months agoWhich Markets Is MiMedx Group Actually Targeting?
Why Investors Are Eyeing MiMedx Group Today
- Market Realist•5 months ago
Understanding MiMedx Group’s Zealous Focus on Sales
Why Investors Are Eyeing MiMedx Group Today
